Global Veterinary Vaccines Market By Disease (Swine Pneumonia, Avian Influenza, Rabies, Coccidiosis, Brucellosis, Canine Distemper), Type (Poultry, Livestock, Aquaculture, Porcine, Canine), Technology (Inactivated, Toxoid, Recombinant), By Region, Industry Analysis, Share, Growth, Trends, and Forecast, 2021-2028

Covid-19 Impact on Global Veterinary Vaccines Market

Type: PDF

Status: Published

Categories: Pharma & Healthcare

Report Code : PHC214033

No. of Pages : 318

The global veterinary vaccines market is expected to grow from USD 8.80 billion in 2019 to USD 16.59 billion by 2028 at a CAGR of 7.3 % over the forecast period 2021-2028.

Market Overview:

Veterinary vaccines play an important role in protecting animal health and public health, reducing animal suffering, enabling efficient food production to feed the burgeoning animal population. It is significantly reducing the necessity for antibiotics to treat food and companion animals. Prominent examples include rabies vaccines and rinderpest vaccines. Rabies vaccines for livestock and wildlife have nearly eliminated human rabies in developed countries. The market has experienced a shift of trend from live attenuated vaccines to DNA vaccines. It is swiftly adopting recombinant vaccine solutions, which can further provide growth opportunities to the present market within the near future.

Market Dynamics:

Drivers:

Constant growth in the animal adoption

Various govt. initiatives supporting animal associations

Restraints:

Huge cost associated with storage of vaccines

Lack of veterinarians and skilled professionals

Key Market Players:

Zoetis, Merck Animal Health, Boehringer Ingelheim, Elanco, Ceva, Virbac, Vetoquinol, Phibro Animal Health, Hester Biosciences, HIPRA, Biogenesis Bago, Tianjin Ringpu, China Animal Husbandry, Jinyu Biotechnology, Endovac Animal Health, Brilliant Bio Pharma Private Limited, Aptimmune Biologics, Indian Immunologicals Ltd., Torigian, and VEROVACCiNES are some of the prominent players in the global veterinary vaccines market.

The market is segmented based on the below-mentioned segments:

On the Basis of Disease: Revenue

o Swine Pneumonia

o Avian Influenza

o Rabies

o Coccidiosis

o Brucellosis

o Canine Distemper

On the Basis of Type: Revenue

o Poultry

o Livestock

o Aquaculture

o Porcine

o Canine

On the Basis of Technology: Revenue

o Inactivated

o Toxoid

o Recombinant

On The Basis of Region: Revenue

North America

- U.S.A
- Canada
- Mexico

Europe

- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe

Asia Pacific

- China
- Japan
- India
- SEA
- Australia
- Rest Of APAC

South America

- Brazil
- Argentina
- Rest of South America

Middle East & Africa

- South Africa
- Saudi Arabia
- UAE
- Rest of MEA

Report Description

Year Consideration
- Base year – 2020
- Historic Year-2017-2019
- Forecast year- 2021 to 2028

The global veterinary vaccines market will be based on revenue and volume. The study covers the market share for segments, countries, regions, and players.

The regions evaluated for the global veterinary vaccines market are Europe, North America, Asia Pacific, South America, and Middle East & Africa. Furthermore, the regions are further analyzed at the country-level.

The report provides an in-depth pricing analysis, value chain analysis, industry road map, and micro and macro factors.

The research report further provides the attractiveness of the veterinary vaccine and regions based on their growth rate (CAGR), market size, and attractiveness by analyzing present and future prospects to analyze market growth and development in the future.

Also, the study focuses on market-related driving forces, restraints, potential opportunities for the market, significant developments, and advancement that serve as a key potential for investors.

The study offers an extensive evaluation of Porter's five forces analysis, SWOT analysis, and PESTEL analysis to provide data and information related to the business.

Porter's five forces model is analyzed to understand the overall competitive scenario that prevails in the market. The SWOT analysis also identifies the positive as well as the negative characteristics of market development which influences the company’s growth and development to sustain and survive in the long run. The PESTEL analysis identifies the macro (external) forces affecting the organization.

The report includes a thorough analysis of the company profiles of major companies operating in the global veterinary vaccines market and a comparative evaluation based on their business overviews, product offering, geographic presence, market share, business strategy, recent developments, product development & innovations, joint ventures, partnerships, mergers & acquisitions, expansions, SWOT analysis, and key financial information. It helps in evaluating the overall competition present in the market scenario.

Request For Request Sample

To receive a sample copy of this report, please complete the form below

Full Name

Company Name

Designation/Position

Contact

Region/Country

Message

Kindly share your specific requirement (if any), so we can get back to you with a solution

TABLE OF CONTENTS
1. INTRODUCTION
1.1. OBJECTIVES OF THE STUDY
1.2. SCOPE OF THE STUDY
1.3. GEOGRAPHIC SCOPE
1.4. MARKET DEFINITION
1.5. CURRENCY CONSIDERATION
1.6. YEAR CONSIDERATION
2. RESEARCH METHODOLOGY AND ASSUMPTIONS
2.1. SECONDARY RESEARCH
2.2. PRIMARY RESEARCH
2.3. MARKET BREAKUP AND DATA TRIANGULATION
2.4. MARKET SIZE ESTIMATION
2.4.1. BOTTOM UP APPROACH
2.4.2. TOP DOWN APPROACH
2.5. ASSUMPTION
3. EXECUTIVE SUMMARY
3.1. KEY MARKET INSIGHTS
3.2. SEGMENTATION OUTLOOK
3.3. COMPANY OUTLOOK
4. PREMIUM INSIGHTS
4.1. IMPACT OF COVID-19 ON MARKET
4.2. INDUSTRY ROAD MAP
4.3. INDUSTRY TREND
4.4. INDUSTRY SWOT ANALYSIS
4.5. MARKET ATTRACTIVENESS ANALYSIS
4.5.1. MARKET ATTRACTIVENESS BY SEGMENTS
4.5.1.1. VETERINARY VACCINES MARKET ATTENTIVENESS BY TYPE
4.5.1.2. VETERINARY VACCINES MARKET ATTENTIVENESS BY DISEASE
4.5.1.3. VETERINARY VACCINES MARKET ATTENTIVENESS BY TECHNOLOGY
4.5.2. MARKET ATTRACTIVENESS BY REGION
4.5.2.1. NORTH AMERICA VETERINARY VACCINES MARKET ATTENTIVENESS BY COUNTRY
4.5.2.2. EUROPE VETERINARY VACCINES MARKET ATTENTIVENESS BY COUNTRY
4.5.2.3. ASIA PACIFIC VETERINARY VACCINES MARKET ATTENTIVENESS BY COUNTRY
4.5.2.4. SOUTH AMERICA VETERINARY VACCINES MARKET ATTENTIVENESS BY COUNTRY
4.5.2.5. MIDDLE EAST AND AFRICA VETERINARY VACCINES MARKET ATTENTIVENESS BY COUNTRY
4.6. PORTER’S FIVE FORCES ANALYSIS
4.6.1. THREAT OF NEW ENTRANTS
4.6.2. THREAT OF SUBSTITUTES
4.6.3. BARGAINING POWER OF SUPPLIERS
4.6.4. BARGAINING POWER OF BUYERS
4.6.5. INTENSITY OF COMPETITIVE RIVALRY
4.7. VALUE CHAIN ANALYSIS
4.7.1. RESEARCH & DEVELOPMENT COMPANIES
4.7.2. RAW MATERIAL/ COMPONENT SUPPLIERS
4.7.3. PRODUCT MANUFACTURERS
4.7.4. DISTRIBUTORS AND RETAILERS
4.7.5. END-USER INDUSTRIES
4.7.6. POST-SALES SERVICE PROVIDERS
4.8. FACTORS AFFECTING THE MARKET
4.8.1. MACRO FACTORS AFFECTING THE MARKET
4.8.2. MICRO FACTORS AFFECTING THE MARKET
4.8.3. PESTEL ANALYSIS
4.9. YEAR ON YEAR GROWTH RATE OF VETERINARY VACCINES
4.10. LIST OF SUPPLIERS
4.11. LIST OF BUYERS
4.12. COUNTRY LEVEL ANALYSIS
4.13. RULES AND REGULATION
5. MARKET DYNAMICS
5.1. MARKET DRIVERS
5.1.1. CONSTANT GROWTH IN THE ANIMAL ADOPTION
5.1.2. VARIOUS GOVT. INITIATIVES SUPPORTING ANIMAL ASSOCIATIONS
5.2. MARKET RESTRAINTS
5.2.1. HUGE COST ASSOCIATED WITH STORAGE OF VACCINES
5.2.2. LACK OF VETERINARIANS AND SKILLED PROFESSIONALS
5.3. MARKET OPPORTUNITIES
5.4. MARKET CHALLENGES
6. GLOBAL VETERINARY VACCINES MARKET INSIGHTS AND FORECAST ANALYSIS, BY DISEASE - 2017-2028
6.1. KEY FINDINGS
6.2. SWINE PNEUMONIA
6.3. AVIAN INFLUENZA
6.4. RABIES
6.5. COCCIDIOSIS
6.6. BRUCELLOSIS
6.7. CANINE DISTEMPER
7. GLOBAL VETERINARY VACCINES MARKET INSIGHTS AND FORECAST ANALYSIS, BY TYPE - 2017-2028
7.1. KEY FINDINGS
7.2. POULTRY
7.3. LIVESTOCK
7.4. AQUACULTURE
7.5. PORCINE
7.6. CANINE
8. GLOBAL VETERINARY VACCINES MARKET INSIGHTS AND FORECAST ANALYSIS, BY TECHNOLOGY - 2017-2028
8.1. KEY FINDINGS
8.2. INACTIVATED
8.3. TOXOID
8.4. RECOMBINANT
9. GLOBAL VETERINARY VACCINES MARKET INSIGHTS AND FORECAST ANALYSIS, BY REGIONAL - 2017-2028
9.1. KEY FINDINGS
9.2. NORTH AMERICA
9.3. EUROPE
9.4. ASIA PACIFIC
9.5. SOUTH AMERICA
9.6. MIDDLE EAST & AFRICA
10. NORTH AMERICA VETERINARY VACCINES MARKET INSIGHTS AND FORECAST ANALYSIS, BY SEGMENTS AND COUNTRY - 2017-2028
10.1. BY COUNTRY
10.1.1. U.S.
10.1.2. CANADA
10.1.3. MEXICO
11. EUROPE VETERINARY VACCINES MARKET INSIGHTS AND FORECAST ANALYSIS, BY SEGMENTS AND COUNTRY - 2017-2028
11.1. BY COUNTRY
11.1.1. GERMANY
11.1.2. U.K.
11.1.3. FRANCE
11.1.4. ITALY
11.1.5. SPAIN
11.1.6. SWEDEN
11.1.7. BELGIUM
11.1.8. TURKEY
11.1.9. RUSSIA
11.1.10. POLAND
11.1.11. SWITZERLAND
11.1.12. NETHERLANDS
11.1.13. REST OF EUROPE
12. ASIA PACIFIC VETERINARY VACCINES MARKET INSIGHTS AND FORECAST ANALYSIS, BY SEGMENTS AND COUNTRY - 2017-2028
12.1. BY COUNTRY
12.1.1.1. JAPAN
12.1.1.2. CHINA
12.1.1.3. INDIA
12.1.1.4. AUSTRALIA
12.1.1.5. SOUTH KOREA
12.1.1.6. MALAYSIA
12.1.1.7. INDONESIA
12.1.1.8. VIETNAM
12.1.1.9. NEW ZEALAND
12.1.1.10. PHILIPPINES
12.1.1.11. TAIWAN
12.1.1.12. SINGAPORE
12.1.1.13. REST OF ASIA-PACIFIC
13. SOUTH AMERICA VETERINARY VACCINES MARKET INSIGHTS AND FORECAST ANALYSIS, BY SEGMENTS AND COUNTRY - 2017-2028
13.1. BY COUNTRY
13.1.1.1. BRAZIL
13.1.1.2. ARGENTINA
13.1.1.3. CHILE
13.1.1.4. COLOMBIA
13.1.1.5. REST OF SOUTH AMERICA
14. MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET INSIGHTS AND FORECAST ANALYSIS, BY SEGMENTS AND COUNTRY - 2017-2028
14.1. BY COUNTRY
14.1.1.1. SOUTH AFRICA
14.1.1.2. U.A.E.
14.1.1.3. SAUDI ARABIA
14.1.1.4. REST OF MIDDLE EAST AND AFRICA
15. COMPETITIVE LANDSCAPE
15.1. MARKET SHARE OF KEY PLAYERS IN POWER TOOL MARKET
15.1.1. GLOBAL MARKET SHARE ANALYSIS
15.1.2. NORTH AMERICA MARKET SHARE ANALYSIS
15.1.3. EUROPE MARKET SHARE ANALYSIS
15.1.4. ASIA PACIFIC MARKET SHARE ANALYSIS
15.1.5. SOUTH AMERICA MARKET SHARE ANALYSIS
15.1.6. MIDDLE EAST & AFRICA MARKET SHARE ANALYSIS
15.2. LEADERSHIP MAPPING
15.2.1. VISIONARY PLAYERS
15.2.2. INNOVATORS PLAYERS
15.2.3. DYNAMIC DIFFERENTIATORS
15.2.4. EMERGING COMPANIES
15.3. COMPETITIVE SCENARIO AND TRENDS
15.3.1. MERGERS & ACQUISITIONS
15.3.2. PRODUCT LAUNCHES AND DEVELOPMENTS
15.3.3. PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS
15.3.4. EXPANSIONS
16. COMPANY PROFILES
16.1.1. ZOETIS
16.1.1.1. COMPANY OVERVIEW
16.1.1.2. COMPANY SNAPSHOT
16.1.1.3. FINANCIAL ANALYSIS
16.1.1.3.1. REVENUE ANALYSIS
16.1.1.3.2. SALES ANALYSIS
16.1.1.3.3. PRICE ANALYSIS
16.1.1.3.4. MARGIN ANALYSIS
16.1.1.4. GEOGRAPHICAL PRESENCE
16.1.1.4.1. NORTH AMERICA
16.1.1.4.2. EUROPE
16.1.1.4.3. ASIA PACIFIC
16.1.1.4.4. SOUTH AMERICA
16.1.1.4.5. MIDDLE EAST & AFRICA
16.1.1.5. PRODUCT PORTFOLIO
16.1.1.6. SWOT ANALYSIS
16.1.1.7. RECENT DEVELOPMENT
16.1.2. MERCK ANIMAL HEALTH
16.1.3. BOEHRINGERINGELHEIM
16.1.4. ELANCO
16.1.5. CEVA
16.1.6. VIRBAC
16.1.7. VETOQUINOL
16.1.8. PHIBRO ANIMAL HEALTH
16.1.9. HESTER BIOSCIENCES
16.1.10. HIPRA
16.1.11. BIOGENESIS BAGO
16.1.12. TIANJIN RINGPU
16.1.13. CHINA ANIMAL HUSBANDRY
16.1.14. JINYU BIOTECHNOLOGY
16.1.15. ENDOVAC ANIMAL HEALTH
16.1.16. BRILLIANT BIO PHARMA PRIVATE LIMITED
16.1.17. APTIMMUNE BIOLOGICS
16.1.18. INDIAN IMMUNOLOGICALS LTD.
16.1.19. TORIGIAN
16.1.20. VEROVACCINES
17. STRATEGIC RECOMMENDATIONS
LIST OF TABLE
1. RESEARCH ASSUMPTION
2. COVID-19 IMPACT ON MARKET
3. MAJOR DEVELOPMENTS BY VARIOUS COMPANIES
4. GLOBAL VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
5. GLOBAL SWINE PNEUMONIA VETERINARY VACCINES MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
6. GLOBAL RABIES VETERINARY VACCINES MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
7. GLOBAL COCCIDIOSIS VETERINARY VACCINES MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
8. GLOBAL BRUCELLOSIS VETERINARY VACCINES MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
9. GLOBAL CANINE DISTEMPER VETERINARY VACCINES MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
10. GLOBAL AVIAN INFLUENZA VETERINARY VACCINES MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
11. GLOBAL VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
12. GLOBAL POULTRY VETERINARY VACCINES MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
13. GLOBAL LIVESTOCK VETERINARY VACCINES MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
14. GLOBAL AQUACULTURE VETERINARY VACCINES MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
15. GLOBAL PORCINE VETERINARY VACCINES MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
16. GLOBAL CANINE VETERINARY VACCINES MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
17. GLOBAL VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
18. GLOBAL INACTIVATED VETERINARY VACCINES , BY REGION, 2017–2028 REVENUE (USD MILLION)
19. GLOBAL TOXOID VETERINARY VACCINES , BY REGION, 2017–2028 REVENUE (USD MILLION)
20. GLOBAL RECOMBINANT VETERINARY VACCINES , BY REGION, 2017–2028 REVENUE (USD MILLION)
21. GLOBAL ACADEMICS & RESEARCH CENTERS VETERINARY VACCINES MARKET, BY REGION, 2017–2028 REVENUE (USD MILLION)
22. GLOBAL VETERINARY VACCINES MARKET, BY NORTH AMERICA, 2017–2028 REVENUE (USD MILLION)
23. NORTH AMERICA VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
24. NORTH AMERICA VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
25. NORTH AMERICA VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
26. U.S. VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
27. U.S. VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
28. U.S. VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
29. CANADA VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
30. CANADA VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
31. CANADA VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
32. MEXICO VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
33. MEXICO VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
34. MEXICO VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
35. EUROPE VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
36. EUROPE VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
37. EUROPE VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
38. GERMANY VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
39. GERMANY VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
40. GERMANY VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
41. FRANCE VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
42. FRANCE VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
43. FRANCE VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
44. U.K. VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
45. U.K. VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
46. U.K. VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
47. ITALY VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
48. ITALY VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
49. ITALY VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
50. SPAIN VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
51. SPAIN VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
52. SPAIN VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
53. SWEDEN VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
54. SWEDEN VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
55. SWEDEN VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
56. BELGIUM VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
57. BELGIUM VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
58. BELGIUM VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
59. TURKEY VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
60. TURKEY VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
61. TURKEY VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
62. RUSSIA VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
63. RUSSIA VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
64. RUSSIA VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
65. POLAND VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
66. POLAND VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
67. POLAND VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
68. SWITZERLAND VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
69. SWITZERLAND VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
70. SWITZERLAND VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
71. NETHERLANDS VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
72. NETHERLANDS VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
73. NETHERLANDS VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
74. ASIA PACIFIC VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
75. ASIA PACIFIC VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
76. ASIA PACIFIC VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
77. JAPAN VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
78. JAPAN VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
79. JAPAN VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
80. CHINA VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
81. CHINA VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
82. CHINA VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
83. INDIA VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
84. INDIA VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
85. INDIA VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
86. AUSTRALIA VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
87. AUSTRALIA VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
88. AUSTRALIA VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
89. SOUTH KOREA VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
90. SOUTH KOREA VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
91. SOUTH KOREA VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
92. INDONESIA VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
93. INDONESIA VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
94. INDONESIA VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
95. VIETNAM VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
96. VIETNAM VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
97. VIETNAM VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
98. NEW ZEALAND VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
99. NEW ZEALAND VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
100. NEW ZEALAND VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
101. PHILIPPINES VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
102. PHILIPPINES VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
103. PHILIPPINES VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
104. TAIWAN VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
105. TAIWAN VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
106. TAIWAN VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
107. SINGAPORE VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
108. SINGAPORE VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
109. SINGAPORE VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
110. SOUTH AMERICA VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
111. SOUTH AMERICA VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
112. SOUTH AMERICA VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
113. BRAZIL VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
114. BRAZIL VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
115. BRAZIL VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
116. ARGENTINA VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
117. ARGENTINA VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
118. ARGENTINA VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
119. CHILE VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
120. CHILE VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
121. CHILE VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
122. COLOMBIA VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
123. COLOMBIA VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
124. COLOMBIA VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
125. MIDDLE EAST AND AFRICA VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
126. MIDDLE EAST AND AFRICA VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
127. MIDDLE EAST AND AFRICA VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
128. UAE VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
129. UAE VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
130. UAE VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
131. SOUTH AFRICA VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
132. SOUTH AFRICA VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
133. SOUTH AFRICA VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
134. SAUDI ARABIA VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
135. SAUDI ARABIA VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
136. SAUDI ARABIA VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)
137. REST OF MEA VETERINARY VACCINES MARKET, BY DISEASE, 2017–2028 REVENUE (USD MILLION)
138. REST OF MEA VETERINARY VACCINES MARKET, BY TYPE, 2017–2028 REVENUE (USD MILLION)
139. REST OF MEA VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2017–2028 REVENUE (USD MILLION)

LIST OF FIGURE
1. RESEARCH DESIGN
2. SCOPE OF THE STUDY
3. GEOGRAPHIC SCOPE
4. CURRENCY CONSIDERATION
5. YEAR CONSIDERATION
6. MARKET ESTIMATION
7. RESEARCH METHODOLOGY
8. DATA TRIANGULATION
9. COVID-19 IMPACT ON MARKET
10. GLOBAL VETERINARY VACCINES MARKET ATTRACTIVENESS ANALYSIS BY TYPE
11. GLOBAL VETERINARY VACCINES MARKET ATTRACTIVENESS ANALYSIS BY DISEASE
12. GLOBAL VETERINARY VACCINES MARKET ATTRACTIVENESS ANALYSIS BY TECHNOLOGY
13. GLOBAL VETERINARY VACCINES MARKET ATTRACTIVENESS ANALYSIS BY REGION
14. GLOBAL VETERINARY VACCINES MARKET ATTRACTIVENESS ANALYSIS BY COUNTRY
15. GLOBAL VETERINARY VACCINES MARKET: DYNAMICS
16. PESTEL ANALYSIS
17. SWOT ANALYSIS
18. GLOBAL VETERINARY VACCINES MARKET ANALYSIS BY REGION
19. GLOBAL VETERINARY VACCINES MARKET ANALYSIS BY TYPE
20. GLOBAL VETERINARY VACCINES MARKET ANALYSIS BY DISEASE
21. GLOBAL VETERINARY VACCINES MARKET ANALYSIS BY TECHNOLOGY
22. GLOBAL VETERINARY VACCINES MARKET ANALYSIS BY NORTH AMERICA
23. GLOBAL VETERINARY VACCINES MARKET ANALYSIS BY EUROPE
24. GLOBAL VETERINARY VACCINES MARKET ANALYSIS BY ASIA PACIFIC
25. GLOBAL VETERINARY VACCINES MARKET ANALYSIS BY SOUTH AMERICA
26. GLOBAL VETERINARY VACCINES MARKET ANALYSIS BY MIDDLE EAST & AFRICA
27. GLOBAL VETERINARY VACCINES MARKET SHARE BY COMPANY (2019)
28. NORTH AMERICA VETERINARY VACCINES MARKET SHARE BY COMPANY (2019)
29. EUROPE VETERINARY VACCINES MARKET SHARE BY COMPANY (2019)
30. ASIA PACIFIC VETERINARY VACCINES MARKET SHARE BY COMPANY (2019)
31. SOUTH AMERICA VETERINARY VACCINES MARKET SHARE BY COMPANY (2019)
32. MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SHARE BY COMPANY (2019)